Amylyx Pharmaceuticals, Inc. AMLX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s total current assets?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported total current assets of $285.02M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s total current assets changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s total current assets increased by 31.9% year-over-year, from $216.14M to $285.02M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s total current assets?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s total current assets has grown at a 32.5% compound annual growth rate (CAGR), from $104.95M to $323.67M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.